72 related articles for article (PubMed ID: 12969534)
1. [Accelerated fractionated radiotherapy with concurrent chemotherapy in advanced nasopharyngeal carcinoma].
Wang RS; Liu WQ; Li J; Zhang Y; Qin YT
Ai Zheng; 2003 Sep; 22(9):982-4. PubMed ID: 12969534
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of accelerated fractionation versus conventional fractionation for nasopharyngeal carcinoma].
Wang YM; Wang F; Fu Q; Kong F; Chen XZ
Ai Zheng; 2008 Dec; 27(12):1283-6. PubMed ID: 19079994
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.
Lee AW; Tung SY; Chan AT; Chappell R; Fu YT; Lu TX; Tan T; Chua DT; O'sullivan B; Xu SL; Pang ES; Sze WM; Leung TW; Kwan WH; Chan PT; Liu XF; Tan EH; Sham JS; Siu L; Lau WH
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):142-51. PubMed ID: 16904519
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity.
Lee AW; Sze WM; Yau TK; Yeung RM; Chappell R; Fowler JF
Radiother Oncol; 2001 Feb; 58(2):121-30. PubMed ID: 11166862
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
7. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
8. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
He XY; Liu TF; He SQ; Huan SL; Pan ZQ
Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma.
Lee AW; Tung SY; Chan AT; Chappell R; Fu YT; Lu TX; Tan T; Chua DT; O'Sullivan B; Tung R; Ng WT; Leung TW; Leung SF; Yau S; Zhao C; Tan EH; Au GK; Siu L; Fung KK; Lau WH
Radiother Oncol; 2011 Jan; 98(1):15-22. PubMed ID: 20971520
[TBL] [Abstract][Full Text] [Related]
10. A phase III study of late course accelerated hyperfractionated radiotherapy versus conventionally fractionated radiotherapy in patients with nasopharyngeal carcinoma.
Pan ZQ; He XY; Guo XM; Ye M; Zhang Z; He SQ; Liu TF
Am J Clin Oncol; 2012 Dec; 35(6):600-5. PubMed ID: 22134512
[TBL] [Abstract][Full Text] [Related]
11. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and outcome for nasopharyngeal carcinoma.
Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
[TBL] [Abstract][Full Text] [Related]
15. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
[TBL] [Abstract][Full Text] [Related]
16. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy with concurrent chemotherapy for treatment of advanced nasopharyngeal carcinoma].
Feng ZF; Pan HL; Song HS; Liu ZM; Huang Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):694-6. PubMed ID: 15201093
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea.
Park KH; Kim JS; Park Y; Seo HY; Park YJ; Choi IK; Oh SC; Seo JH; Kim CY; Jung KY; Shin SW; Kim YH; Kim JS; Lee NJ
Cancer Chemother Pharmacol; 2010 Sep; 66(4):643-51. PubMed ID: 20033411
[TBL] [Abstract][Full Text] [Related]
19. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx.
Levendag PC; Schmitz PI; Jansen PP; Eijkenboom WM; Visser AG; Kolkman-Deurloo IK; Sipkema D; Visch LL; Senan S
J Clin Oncol; 1998 Jun; 16(6):2213-20. PubMed ID: 9626223
[TBL] [Abstract][Full Text] [Related]
20. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
